Susan E. Drozda
Pfizer (United States)(US)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Chemical Synthesis and Analysis, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography
Most-Cited Works
- → A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor(1991)864 cited
- → Discovery of Clinical Candidate 1-{[(2 S ,3 S ,4 S )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design(2017)139 cited
- → The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine as a novel, nonpeptide substance P antagonist(1992)107 cited
- → 5-Phenyl-3-ureidobenzazepin-2-ones as Cholecystokinin-B Receptor Antagonists(1994)70 cited
- → Characterization of Non-peptide Antagonist and Peptide Agonist Binding Sites of the NK1 Receptor with Fluorescent Ligands(1997)62 cited
- → Regioselective synthesis of allyltrimethylsilanes from allylic halides and allylic sulfonates. Application to the synthesis of 2,3-bis(trimethylsilyl)alk-1-enes(1984)54 cited
- → Discovery and Preclinical Characterization of 1-Methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1 H -pyrazolo-[3,4- b ]pyrazine (PF470): A Highly Potent, Selective, and Efficacious Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator(2014)51 cited
- → A highly stereoselective synthesis of the octahydronaphthalene subunit of kijanolide and tetronolide(1988)50 cited
- → Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.(1991)47 cited
- → Structure−Activity Relationships of Potent, Selective Inhibitors of Neuronal Nitric Oxide Synthase Based on the 6-Phenyl-2-aminopyridine Structure(2004)33 cited